Oslo
Norway
12
2015-04-09
11
2016-12-27
These are the the leading inventors for applications assigned to GEMVAX AS:
GEMVAX AS based in Oslo, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Anti-inflammatory peptides and composition comprising the same
#2 | 2015-04-09 ✅ Patent 9,540,419 granted on 2017-01-10Anti-inflammatory peptides and composition comprising the same
#3 | 2012-10-25POLYPEPTIDES
#4 | 2011-05-05 ✅ Patent 8,614,177 granted on 2013-12-24Peptides
#5 | 2008-08-07 ✅ Patent 8,193,326 granted on 2012-06-05Nucleic acids encoding novel TERT polypeptides
#6 | 2007-01-04 ✅ Patent 7,863,244 granted on 2011-01-04Peptides
#7 | 2006-08-31 ✅ Patent 7,375,117 granted on 2008-05-20Polypeptides
#8 | 2006-07-18 ✅ Patent 7,078,416 granted on 2006-07-18Polypeptides
#9 | 2006-05-18 ✅ Patent 7,794,723 granted on 2010-09-14Antigenic peptides derived from telomerase
#10 | 2006-04-18 ✅ Patent 7,030,211 granted on 2006-04-18Antigenic peptides derived from telomerase
#11 | 2005-04-07 ✅ Patent 7,192,927 granted on 2007-03-20Peptides
#12 | 2005-03-01 ✅ Patent 6,861,057 granted on 2005-03-01Immunogenic β-amyloid peptide
90645 ⎘